Test Identifies Ovarian Cancer

Published Online: Friday, October 1, 2004

John Hopkins researchers have developed a test to detect ovarian cancer by identifying 3 proteins found in the blood of women with the disease, according to an article reported in Cancer Research (August 15, 2004). Earlier studies with the test suggested that there is a molecular signature exclusive to ovarian cancer, which can remain undetected and spread quickly.

"By identifying a select group of biomarkers specific to ovarian cancer, we not only know the proteins we are dealing with, but we can trace them back to alterations in the genetic code of ovarian cancer cells," said Daniel W. Chan, PhD, director of Biomarker Discovery Center at Johns Hopkins.

Additional studies are needed, however, before the test is commercially available for screening ovarian cancer. Chan pointed out that no blood test will be able to correctly diagnose 100% of cancerous tumors all the time.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues